Literature DB >> 23960775

Synthesis, SAR and antibacterial activity of hybrid chloro, dichloro-phenylthiazolyl-s-triazines.

Prashant Gahtori1, Surajit Kumar Ghosh, Brijesh Singh, Udaya Pratap Singh, Hans Raj Bhat, Archana Uppal.   

Abstract

A series of hybrid novel chloro (1a-9a) and dichloro (10b-18b) phenylthiazolyl-s-triazine were synthesized and subsequently subjected to their antibacterial activity against three gram positive viz. Lactobacillus casei (NCIM-2651); Bacillus cereus (NCIM-2458); Staphylococcus aureus (NCIM-2120) and three gram negative viz Salmonella typhimurium (NCIM-2501); Escherichia coli (NCIM-2065); Klebsiella aerogenes (NCIM-2098). The SAR studies around the lead compound revealed that introduction of electron withdrawing groups and amino (-NH-) and mercapto (-S-) linker bridge seemed more promising towards antibacterial activity. Moreover, the virtual Molinspiration screenings are in compliance with Ghose's rule.

Entities:  

Keywords:  Amines; Broth dilution assay; Linker bridge; MIC; s-Triazines

Year:  2011        PMID: 23960775      PMCID: PMC3745068          DOI: 10.1016/j.jsps.2011.05.003

Source DB:  PubMed          Journal:  Saudi Pharm J        ISSN: 1319-0164            Impact factor:   4.330


  12 in total

1.  Discovery of new 1,3,5-triazine scaffolds with potent activity against Mycobacterium tuberculosis H37Rv.

Authors:  Naresh Sunduru; Leena Gupta; Vinita Chaturvedi; Richa Dwivedi; Sudhir Sinha; Prem M S Chauhan
Journal:  Eur J Med Chem       Date:  2010-04-20       Impact factor: 6.514

Review 2.  Antibiotic discovery in the twenty-first century: current trends and future perspectives.

Authors:  Stefano Donadio; Sonia Maffioli; Paolo Monciardini; Margherita Sosio; Daniela Jabes
Journal:  J Antibiot (Tokyo)       Date:  2010-06-16       Impact factor: 2.649

3.  EUCAST Definitive Document E.DEF 3.1, June 2000: Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution.

Authors: 
Journal:  Clin Microbiol Infect       Date:  2000-09       Impact factor: 8.067

4.  Synthesis and antibacterial activity of various substituted s-triazines.

Authors:  K Srinivas; U Srinivas; K Bhanuprakash; K Harakishore; U S N Murthy; V Jayathirtha Rao
Journal:  Eur J Med Chem       Date:  2006-07-11       Impact factor: 6.514

5.  Structure-activity relationships of novel antibacterial translation inhibitors: 3,5-diamino-piperidinyl triazines.

Authors:  Yuefen Zhou; Zhongxiang Sun; Jamie M Froelich; Thomas Hermann; Daniel Wall
Journal:  Bioorg Med Chem Lett       Date:  2006-08-04       Impact factor: 2.823

6.  Synthetic antibacterials. I. Nitrofurylvinyl-s-triazine derivatives.

Authors:  S Nishigaki; F Yoneda; H Matsumoto; K Morinaga
Journal:  J Med Chem       Date:  1969-01       Impact factor: 7.446

7.  4-anilinoquinoline triazines: a novel class of hybrid antimalarial agents.

Authors:  Ashok Kumar; Kumkum Srivastava; S Raja Kumar; M I Siddiqi; Sunil K Puri; Jitendra K Sexana; Prem M S Chauhan
Journal:  Eur J Med Chem       Date:  2010-12-09       Impact factor: 6.514

8.  Synthesis and Antibacterial Assessment of N-[4-(4-substituted phenyl)-1,3-thiazol-2-yl]-1,3,5-triazin-2-amine.

Authors:  P Gahtori; A Das; H Bhatt
Journal:  Indian J Pharm Sci       Date:  2009-01       Impact factor: 0.975

9.  Synthesis, structure and anticancer activity of novel alkenyl-1,3,5-triazine derivatives.

Authors:  F Saczewski; A Bułakowska
Journal:  Eur J Med Chem       Date:  2006-03-15       Impact factor: 6.514

10.  Synthesis, antimalarial activity and cytotoxicity of 4-aminoquinoline-triazine conjugates.

Authors:  Sunny Manohar; Shabana I Khan; Diwan S Rawat
Journal:  Bioorg Med Chem Lett       Date:  2009-10-29       Impact factor: 2.823

View more
  2 in total

Review 1.  Recent development of leucyl-tRNA synthetase inhibitors as antimicrobial agents.

Authors:  Panpan Zhang; Shutao Ma
Journal:  Medchemcomm       Date:  2019-05-27       Impact factor: 3.597

2.  Hybrid phenylthiazole and 1,3,5-triazine target cytosolic leucyl-tRNA synthetase for antifungal action as revealed by molecular docking studies.

Authors:  Udaya Pratap Singh; Hans Raj Bhat; Prashant Gahtori; Ramendra K Singh
Journal:  In Silico Pharmacol       Date:  2013-02-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.